Towards an effective HIV vaccine by Rogier Sanders and Godelieve de Bree (Amsterdam UMC)
There is not yet a vaccine against the second deadliest infection in the world after tuberculosis: HIV. Rogier Sanders and Godelieve de Bree of the Amsterdam UMC are optimistic about the possibility of developing one now. It’s for the first time that a vaccine is being developed in one hospital (Amsterdam UMC) from the design phase to the safety and efficacy studies in healthy volunteers. It’s also unique that these studies for an HIV vaccine are being done in the Netherlands.
However, actually making the vaccine for testing in humans is very expensive. Rogier and Godelieve are trying to make that happen and are now looking for funding. The potential impact on treating HIV through this vaccine is enormous!
Explore other Stories:
Knowledge clip Collaborating with external partners
In this Knowledge clip Diane Schöller, Business Developer at IXA, explains, how to start a successful collaboration with external partners Diane will address different topics like: Why collaborate with external partners? What are the different types of collaboration? How to start a collaboration? And what makes a collaboration successful?
Five years of Amsterdam Venture Studios
The academic incubator facility Amsterdam Venture Studios has found its place in the heart of five campus locations in Amsterdam (Startup Village on Amsterdam Science Park, LawHub on Roeterseiland, AVS VU Campus, AVS Humanities Lab on City Centre Campus, HvA Venture Centre at the campus in Zuidoost and AVS ahti near AMC also in Zuidoost). […]
Improved HIV vaccine candidates activating naïve B- cells expressing germline bNAb precursors
Improved HIV vaccine candidates activating naïve B- cells expressing germline bNAb precursors – Licensing opportunity (PDF)